Responsible buyer
Target buyer ICP: Independent US fertility / REI clinics and small groups (1–4 sites) performing roughly 150–750 ART cycles/year, SART member or NASS-direct reporter, without a full-time registry data manager. Beachhead: clinics that missed or nearly missed a prior deadline, recently changed EMR, or are PE-backed roll-ups standardizing reporting ops. Economic buyer: Practice owner / Medical Director / COO.
Cost of the gap
Painful problem ART outcomes are knowable only ~9–10 months after cycle start. Clinics must then assemble patient demographics, diagnoses, procedure parameters, and pregnancy/birth results — often by manually emailing/texting/calling OBs and patients — then pass NASS/SART validation and obtain medical-director verification. Trade press reports ~2 full admin days per 20 patients, up to two-thirds of some embryologists’ time on non-revenue admin, and ~6% human transcription error rates that can move public success statistics.
Outcome
The outcome we sell Specialist-released Reporting-Year Completeness Pack for one clinic and one reporting year: cycle census, outcome-chase status ledger, exception queue with documented non-responses, field-validation clearance log, draft NASS/SART import artifacts (where EMR allows), and medical-director verification binder. Optional year-round Continuity Desk runs monthly chase so December is not a fire drill. Client remains the reporting entity; medical director remains the verifier/signer.
Decision rule
Proceed only when the source record, service boundary, responsible reviewer, and release criteria can be named before work begins.